Recent Finacing
Recent Raise
Syntax Bio is a synthetic biology company that uses its CRISPR-based Cellgorithm™ platform to rapidly program stem cells into therapeutic cell types for next-generation regenerative medicines.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
